Robert J Morff

Title: The Innovative Contributions of Robert J Morff

Introduction

Robert J Morff is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of therapeutic delivery systems, particularly through his innovative patent. His work focuses on improving the administration of orally active therapeutic agents, which is crucial for patient care.

Latest Patents

Robert J Morff holds a patent for a "Delivery device for orally administered therapeutic agents." This invention describes an improved device designed to contain and administer therapeutic agents in a free-flowing form. The device allows for a unit dose of a therapeutic agent to be retained and positioned for oral administration in a tube. This tube is adapted to deliver the dose with a flow of liquid drawn through it by the normal sipping action of a patient. The combination of small particle size and high flow rates into the alimentary canal enables dosage administration with minimal sensed contact with the oral cavity. This invention is particularly advantageous for administering orally active therapeutic agents to pediatric and geriatric patients.

Career Highlights

Robert J Morff is associated with Eli Lilly and Company, a leading pharmaceutical company known for its commitment to innovation in healthcare. His work at Eli Lilly has allowed him to contribute to advancements in therapeutic delivery systems, enhancing patient experiences and outcomes.

Collaborations

Throughout his career, Robert has collaborated with notable colleagues, including Robert Lee Benefiel and John W Clarke. These collaborations have fostered an environment of innovation and have contributed to the development of effective therapeutic solutions.

Conclusion

Robert J Morff's contributions to the field of therapeutic delivery systems exemplify the impact of innovation in healthcare. His patent for a delivery device significantly enhances the administration of therapeutic agents, particularly for vulnerable patient populations. His work continues to influence the pharmaceutical industry and improve patient care.